SynthesisFrontiers in oncology2020

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis.

Alberto Bongiovanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.